TOI
Oncology Institute, Inc.Company with tickers: TOI, DFPH, TOIIW
CIK
1799191
CUSIP
68236X100
Shares Outstanding
99,982,933
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $147,441,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | $-6,513,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-2,492,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.02 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.02 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |